Sarepta to Float New Stock Issue

Sarepta Therapeutics (NASDAQ: SRPT  ) is to make a public offering of its common stock, the company said in an official statement and in an SEC filing.

The company didn't specify when the issue will be floated or how many shares will be offered; speculation is that the company is aiming to raise around $100 million.

Sarepta also didn't specify what the proceeds were to be used for, saying only that they will be used for "general corporate purposes."

The company did reveal that Lazard Capital Markets is the be the sole book runner for the issue.

The company is currently developing Eteplirsen, a treatment for Duchenne muscular dystrophy, a particularly aggressive form of the disorder.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2151474, ~/Articles/ArticleHandler.aspx, 10/22/2014 8:07:05 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement